Elizabeth Scarr

Last updated

Elizabeth Scarr is an Australian scientist. Her research investigates the chemical changes in the brain associated schizophrenia and bipolar disorder.

Contents

Early life and education

Associate Professor Elizabeth Scarr got her BSc honours degree in Pharmacology at Sunderland University, United Kingdom in 1989. She then moved to Canada and finished her PhD in Neuropsychopharmacology at the University of Saskatchewan in 1995. During her PhD candidature in Canada she came to realize when schizophrenia patients shared their experiences with her that she wanted to move in this field of research. [1] She then spent a year as a post doctoral position an worked on rat hypoxic ischaemic models in Dunedin, New Zealand in 1995. [2]

Work

After her postdoc year in New Zealand Elizabeth moved to Melbourne in 1996 and started working with human postmortem tissue at the Rebecca L. Cooper research laboratories which used to be part of the Mental Health research Institute.

Elizabeth has worked as a senior research fellow at the Mental Health Research Institute ( – [2] As Australian Research Council Future Fellow (2010–2014) in the Department of Psychiatry, Elizabeth’s worked with Professor Brian Dean, who is the head of the Rebecca L. Cooper Research Laboratories at the Mental Health Research Institute. Their work lead to the identification of a subgroup of people with schizophrenia who have low levels of the protein, muscarinic M1 receptor and is known to be important in memory and attention. [1] Currently Elizabeth Scarr is an associate professor at the Department of Psychiatry at the University of Melbourne researching the biochemistry of psychiatric disorders such as schizophrenia and bipolar disorder. She also is the project leader of Cooperative Research Centre for Mental Health ( – Present) and the leader of the Psychiatric Neuropathalogy laboratorium at the University of Melbourne ( – Present). [3] Her work is focused on working towards understanding chemical changes that are associated with schizophrenia and bipolar disorder in close collaboration with molecular psychiatry laboratory. [4]

She is affiliated to Australian Society for Psychiatric Research since 2006, Collegium Internationale Neuro-Psychopharmacologicum 2004, Society for Neuroscience since 2003, Australian Neuroscience Society since 1997 and the Australian Society for Medical Research 2000–2007. [2]

Her research has led to the publication of 73 peer reviewed articles and 3 book chapters so far. [2]

Awards and honors

Recently Elizabeth Scarr has been named in the innovation category of the 100 Women of Influence 2014 by Westpac and the Australian financial review. She has been recognised for her large contribution in adding knowledge to the treatment and understanding of Schizophrenia. She is a recipient of several grants and awards. She received an award from Finkel Foundation 2003, the Collegium Internationale Neuro-Psychopharmacologicum in 2000 and the International Congress in Schizophrenia research in 1998. [2]

She has been the recipient of several major grants (see list below) in the last decade. [2]

Related Research Articles

Edwin Fuller Torrey, is an American psychiatrist and schizophrenia researcher. He is Associate Director of Research at the Stanley Medical Research Institute (SMRI) and founder of the Treatment Advocacy Center (TAC), a nonprofit organization whose principal activity is promoting the passage and implementation of outpatient commitment laws and civil commitment laws and standards in individual states that allow people diagnosed with mental illness to be forcibly committed and medicated easily throughout the United States.

Institute of Psychiatry, Psychology and Neuroscience

The Institute of Psychiatry, Psychology and Neuroscience (IoPPN) is a research institution dedicated to discovering what causes mental illness and diseases of the brain. In addition, its aim is to help identify new treatments for them and ways to prevent them in the first place. The IoPPN is a school of King's College London, England, previously known as the Institute of Psychiatry (IoP).

Florey Institute of Neuroscience and Mental Health

The Florey Institute of Neuroscience and Mental Health, more commonly known as the Florey Institute, is an Australian medical research institute that undertakes clinical and applied research into treatments for brain and mind disorders and the cardiovascular system. The Institute's areas of interest include Parkinson's disease, stroke, motor neurone disease, traumatic brain and spinal cord injury, addiction, epilepsy, multiple sclerosis, brain development in premature babies, Huntington's disease, depression, schizophrenia, brain function in health and disease, heart failure, and dementia.

Nancy Coover Andreasen is an American neuroscientist and neuropsychiatrist. She currently holds the Andrew H. Woods Chair of Psychiatry at the University of Iowa Roy J. and Lucille A. Carver College of Medicine.

The Mental Health Research Institute (MHRI) is a former Australian medical research institute that was focused upon improving the diagnosis, treatment and prevention of major mental disorders. The MHRI was active between 1956 and 2012, when it was merged with the Florey Neuroscience Institutes to form the Florey Institute of Neuroscience and Mental Health. Based in Melbourne, Victoria, the research efforts of the MHRI were focused on understanding schizophrenia, bipolar and major mood disorders, and Alzheimer's disease.

Jeffrey Lieberman

Jeffrey Alan Lieberman is an American psychiatrist who specializes in schizophrenia and related psychoses and their associated neuroscience (biology) and drugs. He was principal investigator for CATIE, the largest and longest independent study ever funded by the United States National Institute of Mental Health to examine existing therapies for schizophrenia.

The Semel Institute for Neuroscience and Human Behavior is a research institute of the University of California Los Angeles (UCLA). It includes a number of centers, including the "Center for Neurobehavioral Genetics", which uses DNA sequencing, gene expression studies, bioinformatics, and the genetic manipulation of model organisms to understand brain and behavioral phenotypes.

Maria Luisa Figueira is a Portuguese Consultant psychiatrist, psychiatrist and academic known for her research in clinical and experimental psychopathology and psychopharmacology, particularly in relation to bi-polar disorders and schizophrenia. She is Professor of Psychiatry and Director of the Department of Psychiatry at the University of Lisbon Faculty of Medicine and Head of the Psychiatric Department at the Hospital de Santa Maria in Lisbon.

Anne Farmer is emeritus professor of psychiatric nosology at the Institute of Psychiatry and was formerly lead consultant in the Affective Disorders Unit at the South London and Maudsley NHS Foundation Trust and the trust's director of medical education. Farmer's focus is on genetic research in affective disorders. Farmer was previously professor of psychiatry at the University of Wales College of Medicine.

Professor Susan Rossell is a British researcher based at Swinburne University of Technology specialising in Neuropsychology and Neuroimaging. Originally from Nottingham, UK; she now resides in Melbourne, Australia. Her research on the neuropsychology of schizophrenia and body dysmorphic disorder is internationally recognised.

Leeanne Carey Australian occupational therapist and neuroscientist

Professor Leeanne Carey is a world leading Australian neuroscientist in occupational therapy and stroke rehabilitation and recovery research. She is the founding leader of the Neurorehabilitation and Recovery research group in the Stroke division at the Florey Institute of Neuroscience and Mental Health in Melbourne, Australia, and currently holds a Future Fellowship awarded by the Australian Research Council (ARC).

Shitij Kapur, MBBS, PhD, FMedSci, is the Dean of the Faculty of Medicine Dentistry and Health Sciences and Assistant Vice-Chancellor (Health) of the University of Melbourne. He was formerly Dean and Head of School at the Institute of Psychiatry, Psychology and Neuroscience (IoPPN) at King's College London, and professor of psychiatry at the University of Toronto. Kapur's research has made major contributions to the understanding of psychosis and antipsychotic treatment. From 2010-2015 he co-lead NEWMEDS, an international consortium of scientists from 19 institutions from 9 EU countries, NEWMEDS, one the largest academic-industry research collaboration projects to find new methods for the development of drugs for schizophrenia and depression.

Lori L. Altshuler American psychiatrist

Lori Altshuler was a Professor at the University of California, Los Angeles (UCLA) Department of Psychiatry and Biobehavioral Sciences and held the Julia S. Gouw Endowed Chair for Mood Disorders. Altshuler was the Director of the UCLA Mood Disorders Research Program and the UCLA Women's Life Center, each being part of the Neuropsychiatric Hospital at UCLA.

Jee Hyun Kim Australian behavioral neuroscientist

Jee Hyun Kim is an Australian behavioral neuroscientist whose work focuses on emotional learning and memory during childhood and adolescence. She is an associate professor, principal research fellow, and head of the Molecular Psychiatry Laboratory at the Deakin University School of Medicine, Australia

Judith L. Rapoport American psychiatrist

Judith L. Rapoport is an American psychiatrist. She is the chief of the Child Psychiatry Branch at the National Institute of Mental Health (NIMH), part of the National Institutes of Health (NIH) in Bethesda, Maryland.

Mary Louise Phillips is a Pittsburgh Foundation-Emmerling Endowed Chair in Psychotic Disorders and Professor of Psychiatry and Clinical and Translational Science at the University of Pittsburgh School of Medicine. As the director of the Mood and Brain Laboratory, Phillips performs neuroimaging research designed to elucidate the neuropathophysiological basis of bipolar disorders and associated behavioral traits.

Jayashri Kulkarni is a Professor of Psychiatry at the Alfred Health and Monash University who works in the area of women's mental health. She has written about Premenstrual syndrome. She has used hormones to treat schizophrenia, bipolar disorder and depression in women. She founded and heads the Monash Alfred Psychiatry Research Centre, a clinical psychiatry research centre which currently has more than 160 staff and students.

Dr. Natalie Matosin is an Australian scientist known for research into the causes of stress and its role in mental illness. Matosin's research has been published in academic journals, as well as on The Conversation. Matosin spoke at TEDx Hamburg in June 2017 and is a National Health and Medical Research Council CJ Martin Early Career Research Fellow.

Haim Belmaker Israeli professor of psychiatry

Prof. Robert Haim Belmaker, is an Israeli psychiatrist who has had major academic positions in Israeli psychiatry since 1974. He had a formative influence on biological directions in Israeli psychiatry. He was Hoffer-Vickar Professor of Psychiatry at Ben-Gurion University of the Negev, Beersheva Israel until his retirement and is now Emeritus.

Joseph T. Coyle

Joseph Thomas Coyle Jr. born in Chicago, Illinois, is a psychiatrist and neuroscientist that is known for his work on the neurobiology of mental illness, more specifically on schizophrenia. He is currently the Eben S. Draper Chair of Psychiatry and Neuroscience at Harvard Medical School in Boston, Massachusetts.

References

  1. 1 2 "Foster a Fellow: Department of Psychiatry, University of Melbourne". University of Melbourne. 2014. Retrieved 5 November 2014.
  2. 1 2 3 4 5 6 "find an expert at unimelb". University of Melbourne Find an Expert. University of Melbourne. Retrieved 5 November 2014.
  3. ↑ "LinkedIn". 2014. Retrieved 6 November 2014.
  4. ↑ "The Florey staff directory". The Florey. The Florey Institute of Neuroscience and Mental Health. 2014. Archived from the original on 7 October 2014. Retrieved 6 November 2014.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.